(Q68954583)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2418949%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

title

In vitro synergism between hybrid immunotoxins and chemotherapeutic drugs: relevance to immunotherapy of prostate carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2418949%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

1 reference

1 reference

1 reference

K S Webb

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2418949%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

S N Liberman

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2418949%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

J L Ware

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2418949%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

P J Walther

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2418949%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

publication date

1 January 1986

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2418949%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

28 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2418949%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2418949%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2418949%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

page(s)

100-106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2418949%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00199856

28 September 2019

exact match

0 references

cites work

Augmentation of Cytotoxic Drug Action by Antibodies Directed at Cell Surface

1 reference

12 December 2020

Specific killing of human T-leukemia cells by immunotoxins prepared with ricin A chain and monoclonal anti-human T-cell leukemia antibodies

1 reference

12 December 2020

Monoclonal antibodies to different epitopes on a prostate tumor-associated antigen. Implications for immunotherapy

1 reference

12 December 2020

In vitro enhancement of adriamycin cytotoxicity in human myeloid leukemia cells exposed to verapamil.

1 reference

12 December 2020

Mechanism of action of the toxic lectins abrin and ricin

1 reference

12 December 2020

Immunotoxins: hybrid molecules combining high specificity and potent cytotoxicity

1 reference

12 December 2020

Heterogeneous expression of cell-surface antigens in normal epithelia and their tumours, revealed by monoclonal antibodies

1 reference

12 December 2020

Evidence for a novel hybrid immunotoxin recognizing ricin A-chain by one antigen-combining site and a prostate-restricted antigen by the remaining antigen-combining site: potential for immunotherapy

1 reference

12 December 2020

Synergistic effects of active specific immunotherapy and chemotherapy in guinea pigs with disseminated cancer

1 reference

12 December 2020

Spontaneous metastasis of cells of the human prostate carcinoma cell line PC-3 in athymic nude mice

1 reference

12 December 2020

Concentration and time-dependent inter-relationships for antitumour drug cytotoxicities against tumour cells in vitro

1 reference

12 December 2020

Changes in susceptibility to cytotoxic antibody among tumor cells surviving exposure to chemotherapeutic agents

1 reference

12 December 2020

Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies.

1 reference

12 December 2020

Immunotoxin-mediated elimination of clonogenic tumor cells in the presence of human bone marrow.

1 reference

12 December 2020

Chemotherapy-increased antineoplastic effects of antibody-toxin conjugates

1 reference

12 December 2020

Isolation of a human prostate carcinoma cell line (DU 145)

1 reference

12 December 2020

Monoclonal antibody-ricin or ricin A chain hybrids: kinetic analysis of cell killing for tumor therapy

1 reference

12 December 2020

Establishment and characterization of a human prostatic carcinoma cell line (PC-3)

1 reference

12 December 2020

Antibody Mediated Delivery of Toxic Molecules to Antigen Bearing Target Cells

1 reference

12 December 2020

Human melanoma cells can be killed in vitro by an immunotoxin specific for melanoma-associated antigen p97

1 reference

12 December 2020

Inhibition of Human Acute Lymphoblastic Leukemia Cells by Immunotoxins: Potentiation by Chloroquine

1 reference

12 December 2020

Immunotoxins: A New Approach to Cancer Therapy

1 reference

12 December 2020

Factors influencing phenotypic diversity of human prostate carcinoma cells metastasizing in athymic nude mice.

1 reference

12 December 2020

Humoral immunostimulation. IX. Selective growth inhibition of L cells in vitro with cytosine arabinoside and antibody

1 reference

12 December 2020

Increased efficiency in selective elimination of leukemia cells by a combination of a stable derivative of cyclophosphamide and a human B-cell-specific immunotoxin containing pokeweed antiviral protein

1 reference

12 December 2020

Antibody-induced cell-cycle synchrony

1 reference

12 December 2020

Properties of immunotoxins against a glycolipid antigen associated with Burkitt's lymphoma

1 reference

12 December 2020

Characterization of prostate-tissue-directed monoclonal antibody, ?-Pro 13

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00199856

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2418949%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

1 reference